CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
247 hedge funds and large institutions have $3.5B invested in Clovis Oncology, Inc. in 2017 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 93 increasing their positions, 88 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
16% less capital invested
Capital invested by funds: $4.15B → $3.5B (-$657M)
56% less funds holding in top 10
Funds holding in top 10: 9 → 4 (-5)
Holders
247
Holding in Top 10
4
Calls
$191M
Puts
$81.1M
Top Buyers
| 1 | +$89.8M | |
| 2 | +$59.6M | |
| 3 | +$36.7M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.4M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$27.2M |
Top Sellers
| 1 | -$83.5M | |
| 2 | -$41.2M | |
| 3 | -$31.9M | |
| 4 |
O
OrbiMed
New York
|
-$28.4M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$18.2M |